- $295.74m
- $253.78m
- $244.38m
- 100
- 59
- 37
- 71
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 20-F | 20-F | 20-F | 20-F | 20-F |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 200 | 221 | 249 | 275 | 244 |
Cost of Revenue | |||||
Gross Profit | 95 | 150 | 171 | 179 | 158 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Total Operating Expenses | 210 | 182 | 209 | 244 | 230 |
Operating Profit | -9.55 | 38.4 | 39.5 | 31.3 | 14.4 |
Total Net Non Operating Interest Income / Expense | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -11.3 | 36.6 | 39.6 | 34.2 | 14.4 |
Provision for Income Taxes | |||||
Net Income After Taxes | 3.98 | 27.2 | 33.8 | 28.5 | 8.78 |
Net Income Before Extraordinary Items | |||||
Net Income | 3.98 | 27.2 | 33.8 | 28.5 | 8.78 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 3.98 | 27.2 | 33.8 | 28.5 | 8.78 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.129 | 0.828 | 0.997 | 0.876 | 0.278 |
Dividends per Share |